Background and Purpose: Transurethral resection of the bladder (TURB), the first step in treatment of patients with urothelial bladder cancers, is limited by technicalities, surgeon skill, and random chance. When high-risk superficial diseases are discovered, a repeated TURB is indicated. We reviewed current literature and performed a meta-analysis of the role of repeated TURB in the management of nonmuscle-invasive bladder cancers. Methods: PubMed, MEDLINE, ISI Web of Knowledge, EBSCO, EMBASE, and Biomed Central databases were searched for reports in English from 1980 to June 2010. The end point was prevalence of persistent urothelial bladder cancer of any stage and grade at repeated TURB, assessed separately for Ta and T1 lesions at TURB. Persistence was presence at repeated TURB of same or lower stage cancer as at TURB; upstaging was presence of higher stage. Results: There were 2327 original articles and 562 reviews retrieved. Data from 15 studies were pooled and analyzed. Prevalence of T1 was reported in all and of Ta in 8. Persistence rate prevalence at repeated TURB was 0.39 (95% confidence interval [CI] = 0.26 to 0.54) for Ta and 0.47 (95% CI = 0.41 to 0.53) for T1. Persistence was 19.4% to 56% and 15.2% to 55%, and upstaging occurred in 0% to 14.3% of Ta and 0% to 24.4% of T1 at repeated TURB, respectively. Conclusion: High percentages of persistence and upstaging confirm a repeated TURB is needed in patients with high-risk nonmuscle-invasive bladder cancer. Further investigation is encouraged taking risk stratification into consideration to evaluate the role of repeated TURB in low- and mid- risk diseases
Repeated White Light Transurethral Resection of the Bladder in Nonmuscle-Invasive Urothelial Bladder Cancers: Systematic Review and Meta-Analysis.
VIANELLO, ALBERTO;COSTANTINI, Elisabetta;DEL ZINGARO, Michele;BINI, Vittorio;PORENA, Massimo
2011
Abstract
Background and Purpose: Transurethral resection of the bladder (TURB), the first step in treatment of patients with urothelial bladder cancers, is limited by technicalities, surgeon skill, and random chance. When high-risk superficial diseases are discovered, a repeated TURB is indicated. We reviewed current literature and performed a meta-analysis of the role of repeated TURB in the management of nonmuscle-invasive bladder cancers. Methods: PubMed, MEDLINE, ISI Web of Knowledge, EBSCO, EMBASE, and Biomed Central databases were searched for reports in English from 1980 to June 2010. The end point was prevalence of persistent urothelial bladder cancer of any stage and grade at repeated TURB, assessed separately for Ta and T1 lesions at TURB. Persistence was presence at repeated TURB of same or lower stage cancer as at TURB; upstaging was presence of higher stage. Results: There were 2327 original articles and 562 reviews retrieved. Data from 15 studies were pooled and analyzed. Prevalence of T1 was reported in all and of Ta in 8. Persistence rate prevalence at repeated TURB was 0.39 (95% confidence interval [CI] = 0.26 to 0.54) for Ta and 0.47 (95% CI = 0.41 to 0.53) for T1. Persistence was 19.4% to 56% and 15.2% to 55%, and upstaging occurred in 0% to 14.3% of Ta and 0% to 24.4% of T1 at repeated TURB, respectively. Conclusion: High percentages of persistence and upstaging confirm a repeated TURB is needed in patients with high-risk nonmuscle-invasive bladder cancer. Further investigation is encouraged taking risk stratification into consideration to evaluate the role of repeated TURB in low- and mid- risk diseasesI documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
